Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00230308 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborators: 2 to 3v26
  2. Collaborators expanded, about 9 wordsv25
  3. 2 versions Re-verified since Sep 9, 2022, no change to tracked fieldsv23-v24
  4. Trial status: Suspended to Recruiting
    • Site details revised
    v22
  5. Trial status: Recruiting to Suspended Sponsor's reason: Suspended due to Covid-19v21 Show 4 more changesShow less
    • Primary completion date: Dec 2019 to Jun 2030
    • Study completion date: Dec 2024 to Dec 2030
    • Start date: Apr 2002 to Apr 2, 2002
    • Site details revised
Show 19 earlier versionsHide 19 earlier versions
  1. Site contact updatedv20
  2. Site contact updatedv19
  3. Site contact updatedv18
  4. Site contact updatedv17
  5. Site contact updatedv16
  6. 2 versions Re-verified since May 31, 2013, no change to tracked fieldsv14-v15
  7. Primary completion date: Dec 2011 to Dec 2019
    • Study completion date: Dec 2011 to Dec 2024
    • Study title expanded, about 2 words
    v13
  8. Primary completion date: Dec 2010 to Dec 2011
    • Collaborators shortened, about 5 words
    v12
  9. Site contact updatedv11
  10. 2 versions Re-verified since Jun 1, 2010, no change to tracked fieldsv9-v10
  11. Primary completion date: Dec 2010
    • Study completion date: Dec 2011
    • Site contact updated
    v8
  12. Re-verified, no change to tracked fieldsv7
  13. Study site revisedv6
  14. 2 versions Re-verified since Apr 25, 2007, no change to tracked fieldsv4-v5
  15. Eligibility criteria expanded, about 6 words
    • Site contact updated
    • Study title expanded, about 1 word
    v3
  16. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
Trial Details
NCT Number NCT00230308
Lead Sponsor Stanford University
Collaborators: National Cancer Institute (NCI), National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR)
Conditions
(from sponsor)		 Head and Neck Cancer
Related terms Head and Neck Neoplasms
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov